Anzeige
Mehr »
Login
Sonntag, 20.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Der Warren Buffett des Bergbaus schlägt wieder zu: NexGold Mining auf dem Weg zur Milliardenbewertung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
485 Leser
Artikel bewerten:
(2)

Swisher Hygiene Inc. To File Current Report On Form 8-K, Reporting Liquidation Basis Accounting For The Seven Months Ended July 31, 2021 And The Year Ended December 31, 2020 And The Filing Of A Motion For Approval To Make A Second And Final Distribution T

FORT LAUDERDALE, FL / ACCESSWIRE / August 31, 2021 / Swisher Hygiene Inc. (the "Company") today reported liquidation basis accounting for the seven months ended July 31, 2021 and the year ended December 31, 2020.

As previously announced, on August 12, 2016, the Securities and Exchange Commission (the "SEC") granted the Company's request for no-action relief from filing future periodic reports under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 beginning with its quarterly report on Form 10-Q for the quarter ended June 30, 2016. In accordance with the terms of the requested relief, the Company will disclose material developments relating to its (i) liquidation, including the amounts of any liquidation distributions, payments and expenses, (ii) dissolution, (iii) financial condition, and (iv) other material developments, including material developments relating to Honeycrest Holdings, Ltd. v. Integrated Brands, Inc. litigation, on Current Reports on Form 8-K.

As a result of the SEC's granting of relief, the Company was relieved of its obligation to file periodic reports for the quarter ended June 30, 2016 or any quarterly or annual period thereafter. However, the Company did provide its initial post-adoption consolidated financial statements for the period from April 1, 2016 to June 30, 2016 prepared on the liquidation basis of accounting on a Current Report on Form 8-K filed with the SEC on August 19, 2016. Additionally, the Company has also provided its audited consolidated financial statements for the period from April 1, 2016 to December 31, 2016, and the years ended December 31, 2017, 2018, 2019 and 2020 in Current Reports on Form 8-K filed with the SEC on April 12, 2017, April 27, 2018, April 2, 2019, March 20, 2020 and March 30, 2021, respectively.

Although not required to do so as a result of obtaining no action relief mentioned above from the SEC, the Company is providing its audited consolidated financial statements for the seven months ended July 31, 2021 and the year ended December 31, 2020 in a Current Report on Form 8-K to be filed with the SEC today. This is the final set of audited financial statements to be published by the Company and filed in a Current Report on Form 8-K with the SEC.

Further, the Company today announced that it filed a motion with the Court of Chancery of the State of Delaware (the "Delaware Court") seeking approval to make a second and final liquidating distribution of approximately $2.1 million to its stockholders (the "Second and Final Distribution"). As previously announced, on August 3, 2021, the Company and Honeycrest Holdings, Ltd. ("Honeycrest") entered into a final settlement agreement (the "Settlement Agreement") that removed the final obstacle to the completion of Swisher's dissolution. The Settlement Agreement was approved by the Delaware Court on August 6, 2021. The Company expects to announce the timing and terms of the Second and Final Distribution through a public release and the filing of a Form 8-K with the Securities and Exchange Commission.

Cautionary Statement on Forward-Looking Information

All statements other than statements of historical fact contained in this press release constitute "forward-looking information" or "forward-looking statements" within the meaning of the U.S. federal securities laws and the Securities Act (Ontario) and are based on the expectations, estimates and projections of management as of the date of this press release unless otherwise stated. All statements other than historical facts are, or may be, deemed to be forward looking statements. The words "plans," "expects," "is expected," "scheduled," "estimates," or "believes," or similar words or variations of such words and phrases or statements that certain actions, events or results "may," "could," "would," "might," or "will be taken," "occur," and similar expressions identify forward-looking statements.

Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. All of these assumptions have been derived from information currently available to the Company including information obtained by the Company from third-party sources. These assumptions may prove to be incorrect in whole or in part. All of the forward-looking statements made in this press release are qualified by the above cautionary statements. The forward-looking information set forth in this press release is subject to various assumptions, risks, uncertainties and other factors that are difficult to predict and which could cause actual results to differ materially from those expressed or implied in the forward-looking information. The Company disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.

About Swisher Hygiene Inc.

Swisher Hygiene Inc. closed on the sale of its U.S. operations to Ecolab Inc. on November 2, 2015 and as a result has no remaining operating assets. On Friday, May 27, 2016 (the "Final Record Date"), the Company filed a Certificate of Dissolution. Pursuant to the Plan of Dissolution, and under Delaware law, the dissolution of the Company was effective as of 6:00 p.m. Eastern Time on the Final Record Date. Under Delaware law, the dissolved corporation is continued for three (3) years from the date on which the Certificate of Dissolution was filed, unless extended by direction of the Court of Chancery, to enable the Company's directors to wind up the affairs of the corporation, including the discharge of the Company's liabilities and to distribute to the stockholders any remaining assets. The Court of Chancery has extended the Company's corporate existence, most recently through December 31, 2021, however, the Company expects its existence to end prior to that date. After making its Second and Final Distribution and obtaining Delaware Court approval, the Company expects to file a final Current Report on Form 8-K and a Form 15 to deregister its common stock when the dissolution is complete. For more information, please visit www.swshinvestors.com.

For Further Information, Please Contact:
Swisher Hygiene Inc.
Investor Contact:
Garrett Edson, ICR
Phone: (203) 682-8331

SOURCE: Swisher Hygiene Inc.



View source version on accesswire.com:
https://www.accesswire.com/662290/Swisher-Hygiene-Inc-To-File-Current-Report-On-Form-8-K-Reporting-Liquidation-Basis-Accounting-For-The-Seven-Months-Ended-July-31-2021-And-The-Year-Ended-December-31-2020-And-The-Filing-Of-A-Motion-For-Approval-To-Make-A-Second-And-Final-Distribution

© 2021 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.